Matt Abernethy

Insider Reports History

Entity
Individual
Location
C/O Neurocrine Biosciences, Inc., 12780 El Camino Real, San Diego, California
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matt Abernethy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NEUROCRINE BIOSCIENCES INC Chief Financial Officer Common Stock 31.5K $4.74M $150.38 Aug 13, 2024 Direct
NEUROCRINE BIOSCIENCES INC Chief Financial Officer Restricted Stock Unit 8.97K $388K $43.24 Feb 13, 2024 Direct
NEUROCRINE BIOSCIENCES INC Chief Financial Officer Non-Qualified Stock Option 0 $0 $73.60 Aug 13, 2024 Direct
NEUROCRINE BIOSCIENCES INC Chief Financial Officer Stock Option 45.1K Feb 13, 2024 Direct

Insider Reports Filed by Matt Abernethy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NBIX NEUROCRINE BIOSCIENCES INC Aug 13, 2024 3 -$1.08M 4 Aug 15, 2024 Chief Financial Officer
NBIX NEUROCRINE BIOSCIENCES INC Jul 16, 2024 3 -$68.8K 4 Jul 18, 2024 Chief Financial Officer
NBIX NEUROCRINE BIOSCIENCES INC May 14, 2024 6 -$4.14M 4 May 16, 2024 Chief Financial Officer
NBIX NEUROCRINE BIOSCIENCES INC Feb 13, 2024 3 -$180K 4 Feb 15, 2024 Chief Financial Officer
NBIX NEUROCRINE BIOSCIENCES INC Feb 6, 2024 2 -$314K 4 Feb 8, 2024 Chief Financial Officer
NBIX NEUROCRINE BIOSCIENCES INC Jan 31, 2024 1 -$181K 4 Feb 2, 2024 Chief Financial Officer
NBIX NEUROCRINE BIOSCIENCES INC Aug 21, 2023 1 -$229K 4 Aug 23, 2023 Chief Financial Officer
NBIX NEUROCRINE BIOSCIENCES INC Feb 13, 2023 2 $0 4 Feb 15, 2023 Chief Financial Officer
NBIX NEUROCRINE BIOSCIENCES INC Feb 6, 2023 5 -$2.93M 4 Feb 8, 2023 Chief Financial Officer
NBIX NEUROCRINE BIOSCIENCES INC Jan 31, 2023 1 -$141K 4 Feb 2, 2023 Chief Financial Officer
NBIX NEUROCRINE BIOSCIENCES INC Feb 7, 2022 3 -$345K 4 Feb 9, 2022 Chief Financial Officer
NBIX NEUROCRINE BIOSCIENCES INC Jan 31, 2022 2 $0 4 Feb 2, 2022 Chief Financial Officer
NBIX NEUROCRINE BIOSCIENCES INC Dec 1, 2021 1 -$136K 4 Dec 3, 2021 Chief Financial Officer